Ledyard National Bank’s Edwards Lifesciences EW Stock Holding History

Ledyard National Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47M	Buy	16,218 +6	+0%	+$503	0.12%	109
2026 Q1	$1.3M	Sell	16,212 -50	-0.3%	-$4.12K	0.11%	108
2025 Q4	$1.39M	Buy	16,262 +1,923	+13%	+$158K	0.12%	101
2025 Q3	$1.12M	Sell	14,339 -49	-0.3%	-$3.83K	0.1%	109
2025 Q2	$1.13M	Sell	14,388 -2,947	-17%	-$220K	0.11%	105
2025 Q1	$1.26M	Sell	17,335 -535	-3%	-$38.3K	0.12%	98
2024 Q4	$1.32M	Sell	17,870 -1	-0%	-$70	0.12%	96
2024 Q3	$1.18M	Sell	17,871 -56	-0.3%	-$4.07K	0.11%	102
2024 Q2	$1.66M	Sell	17,927 -111	-0.6%	-$9.83K	0.16%	86
2024 Q1	$1.72M	Buy	18,038 +14	+0.1%	+$1.18K	0.17%	84
2023 Q4	$1.37M	Sell	18,024 -1,754	-9%	-$122K	0.14%	91
2023 Q3	$1.37M	Hold	19,778	–	–	0.16%	85
2023 Q2	$1.87M	Sell	19,778 -146	-0.7%	-$12.7K	0.2%	82
2023 Q1	$1.65M	Sell	19,924 -700	-3%	-$55K	0.19%	87
2022 Q4	$1.54M	Sell	20,624 -2,076	-9%	-$160K	0.18%	93
2022 Q3	$1.88M	Sell	22,700 -198	-0.9%	-$19.1K	0.24%	84
2022 Q2	$2.18M	Sell	22,898 -271	-1%	-$28.1K	0.26%	83
2022 Q1	$2.73M	Sell	23,169 -1,024	-4%	-$115K	0.27%	83
2021 Q4	$3.13M	Sell	24,193 -949	-4%	-$111K	0.3%	79
2021 Q3	$2.85M	Sell	25,142 -600	-2%	-$68.5K	0.29%	80
2021 Q2	$2.67M	Sell	25,742 -30	-0.1%	-$2.83K	0.27%	83
2021 Q1	$2.16M	Sell	25,772 -80	-0.3%	-$6.76K	0.23%	91
2020 Q4	$2.36M	Sell	25,852 -610	-2%	-$50.6K	0.27%	87
2020 Q3	$2.11M	Sell	26,462 -315	-1%	-$24.6K	0.27%	84
2020 Q2	$1.85M	Sell	26,777 -427	-2%	-$30.3K	0.25%	89
2020 Q1	$1.71M	Buy	27,204 +855	+3%	+$61.7K	0.26%	99
2019 Q4	$2.05M	Sell	26,349 -120	-0.5%	-$9.37K	0.25%	105
2019 Q3	$1.94M	Sell	26,469 -1,065	-4%	-$74.8K	0.26%	98
2019 Q2	$1.7M	Buy	27,534 +150	+0.5%	+$9.07K	0.23%	108
2019 Q1	$1.75M	Sell	27,384 -21,618	-44%	-$1.23M	0.23%	107
2018 Q4	$2.5M	Sell	49,002 -3,255	-6%	-$165K	0.33%	95
2018 Q3	$3.03M	Sell	52,257 -106,257	-67%	-$5.2M	0.35%	93
2018 Q2	$7.69M	Sell	158,514 -3,333	-2%	-$156K	0.92%	30
2018 Q1	$7.53M	Buy	161,847 +4,275	+3%	+$186K	0.92%	31
2017 Q4	$5.92M	Buy	157,572 +9,564	+6%	+$351K	0.72%	51
2017 Q3	$5.39M	Sell	148,008 -3,660	-2%	-$140K	0.72%	49
2017 Q2	$5.98M	Buy	151,668 +3,510	+2%	+$128K	0.86%	39
2017 Q1	$4.65M	Buy	148,158 +146,730	+10,275%	+$4.59M	0.7%	53
2016 Q4	$45K	Hold	1,428	–	–	0.01%	322
2016 Q3	$57K	Hold	1,428	–	–	0.01%	309
2016 Q2	$47K	Hold	1,428	–	–	0.01%	306
2016 Q1	$42K	Hold	1,428	–	–	0.01%	340
2015 Q4	$38K	Hold	1,428	–	–	0.01%	349
2015 Q3	$34K	Hold	1,428	–	–	0.01%	345
2015 Q2	$34K	Hold	1,428	–	–	0.01%	351
2015 Q1	$34K	Hold	1,428	–	–	0.01%	335
2014 Q4	$30K	Hold	1,428	–	–	0.01%	357
2014 Q3	$24K	Hold	1,428	–	–	﹤0.01%	337
2014 Q2	$20K	Hold	1,428	–	–	﹤0.01%	376
2014 Q1	$18K	Hold	1,428	–	–	﹤0.01%	381
2013 Q4	$16K	Buy	+1,428	New	+$16.1K	﹤0.01%	407

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Ledyard National Bank's EW Position: Q2 2026 in Review

Ledyard National Bank increased its Edwards Lifesciences (EW) stake by 0.04% in Q2 2026, buying an estimated $503 and bringing the position to 16,218 shares worth $1.47M. The position accounts for 0.12% of the portfolio, ranked #109.

Ledyard National Bank first reported a position in EW in Q4 2013 and has held it in 51 quarters since. The position peaked at $7.69M in Q2 2018. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Ledyard National Bank held 16,218 shares of Edwards Lifesciences worth $1.47M as of Q2 2026.
Ledyard National Bank bought 6 Edwards Lifesciences shares in Q2 2026, an estimated $503.
Edwards Lifesciences made up 0.12% of Ledyard National Bank's portfolio in Q2 2026, its #109 holding.
Ledyard National Bank first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 51 quarters since.
Ledyard National Bank's Edwards Lifesciences position peaked at $7.69M in Q2 2018.
563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.